go back

Rhode Island rates for HCPCS Q2054

Lisocabtagene maraleucel, up to 110 million autologous anti-CD19 CAR-positive viable T cells, including leukapheresis and dose preparation procedures, per therapeutic dose

Facilitymedian $562,341 · 10th–90th $562,341–$1,096,4780%50%90th$562,341Professionalmedian $562,341 · 10th–90th $562,341–$660,6930%50%90th$562,341$100.0K$200.0K$500.0K$1.0M

Distribution of negotiated rates across all payers (price axis is log-scale). Facility and professional rates are different services and are charted separately. Small sample — interpret with caution. Need provider-level prices? Contact us.

Insurance Carrier
Aetna
Facility/Professional
Facility
Modifier
Typical Low / Median / Typical High
$1,096,478.20 / $1,096,478.20 / $1,096,478.20
Aetna
Facility/Professional
Professional
Modifier
Typical Low / Median / Typical High
$562,341.33 / $562,341.33 / $660,693.45
BCBS
Facility/Professional
Facility
Modifier
Typical Low / Median / Typical High
$562,341.33 / $562,341.33 / $588,843.66
BCBS
Facility/Professional
Professional
Modifier
Typical Low / Median / Typical High
$562,341.33 / $562,341.33 / $562,341.33
Cigna
Facility/Professional
Professional
Modifier
Typical Low / Median / Typical High
$562,341.33 / $562,341.33 / $676,082.98
United
Facility/Professional
Facility
Modifier
Typical Low / Median / Typical High
$562,341.33 / $562,341.33 / $562,341.33
United
Facility/Professional
Professional
Modifier
Typical Low / Median / Typical High
$61,659.50 / $512,861.38 / $562,341.33